EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antidepressant Use During Pregnancy and Birth Outcomes: Analysis From the UK , Norway, and Sweden

Florence Z Martin iD, Viktor H Ahlqvist, Paul Madley-Dowd iD, Michael Lundberg iD, Jacqueline M Cohen, Kari Furu iD, Dheeraj Rai, Harriet Forbes, Kayleigh Easey, Siri E Håberg, Gemma C Sharp, Cecilia Magnusson und 1 weitere

Pharmacoepidemiology and Drug Safety · 2026-09 · 35 (9)

DOI: 10.1002/pds.70446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 12.08.2026. Verfasst von Florence Z Martin und 12 weiteren Autor:innen. Beteiligte Einrichtung: MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK. Hauptthemen laut MEDLINE: Antidepressive Agents, Stillbirth, Pregnancy Complications, Premature Birth. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norges Forskningsråd, Wellcome Trust, H2020 European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Although antidepressant use during pregnancy has been linked to adverse birth outcomes such as stillbirth and preterm delivery, existing evidence is conflicting and rarely presents absolute risk estimates. We aimed to assess the association between antidepressant use during pregnancy and birth outcomes, alongside estimates of absolute risk to aid clinical interpretation.

Methods

We conducted a multi‐country cohort study using data from the UK Clinical Practice Research Datalink (1996–2018), Norwegian Medical Birth Registry (2009–2020), and Swedish Medical Birth Register (2006–2020). Discordant sibling analyses and paternal negative controls were used to investigate associations with stillbirth, neonatal death, gestational age, size for gestational age, and Apgar score < 7 at 5‐min among pregnancies delivered at ≥ 22 weeks' gestation.

Results

Among 120 209 (4.8%) pregnancies exposed to antidepressants, maternal use was associated with stillbirth (adjusted pooled odds ratio [aOR] 1.16, 95% CI 1.05–1.28), preterm delivery (aOR 1.26, 95% CI 1.23–1.30), and low Apgar score (aOR 1.83, 95% CI 1.75–1.91). Associations persisted in sibling analyses with greater uncertainty. The predicted absolute risk of stillbirth was 0.34% among unexposed pregnancies and 0.40% among exposed. When restricting to mothers with depression or anxiety, the association with stillbirth attenuated (aOR 1.07, 95% CI 0.94–1.21). Paternal antidepressant use was modestly associated with preterm delivery and low Apgar score.

Conclusions

Maternal antidepressant use during pregnancy may be associated with increased risks of preterm delivery and low Apgar score, though absolute risks remain low. Residual confounding related to parental mental health is likely to explain part of these associations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antidepressive AgentsStillbirthPregnancy ComplicationsPremature BirthPregnancy OutcomeHumansFemalePregnancyNorwaySwedenUnited KingdomAdultInfant, NewbornCohort StudiesRegistriesGestational AgeApgar ScoreYoung Adult

Substanzen

Antidepressive Agents

Autor:innen und Institutionen

  • MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
  • Population Health Sciences, University of Bristol, Bristol, UK.
  • Centre for Academic Mental Health, University of Bristol, Bristol, UK.
  • Centre for Fertility and Health, Norwegian Institute for Public Health, Oslo, Norway.
  • Epidemiology and Scientific Strategy, IQVIA, London, UK.
  • Department of Biomedicine, Aarhus University, Aarhus, Denmark.

ORCID-Profile: Florence Z Martin, Paul Madley-Dowd, Michael Lundberg, Kari Furu

Förderung

  • Norges Forskningsråd
  • Wellcome Trust
  • H2020 European Research Council

Zitieren

APA

Martin, F. Z., Ahlqvist, V. H., Madley-Dowd, P., Lundberg, M., Cohen, J. M., Furu, K., Rai, D., Forbes, H., Easey, K., Håberg, S. E., Sharp, G. C., Magnusson, C., & Magnus, M. C. (2026). Antidepressant Use During Pregnancy and Birth Outcomes: Analysis From the UK , Norway, and Sweden. Pharmacoepidemiology and Drug Safety, 35(9). https://doi.org/10.1002/pds.70446

Vancouver

Martin FZ, Ahlqvist VH, Madley-Dowd P, Lundberg M, Cohen JM, Furu K, et al. Antidepressant Use During Pregnancy and Birth Outcomes: Analysis From the UK , Norway, and Sweden. Pharmacoepidemiology and Drug Safety. 2026;35(9). doi:10.1002/pds.70446

BibTeX
@article{Martin2026,
  author = {Martin, Florence Z and Ahlqvist, Viktor H and Madley-Dowd, Paul and Lundberg, Michael and Cohen, Jacqueline M and Furu, Kari and Rai, Dheeraj and Forbes, Harriet and Easey, Kayleigh and Håberg, Siri E and Sharp, Gemma C and Magnusson, Cecilia and Magnus, Maria C},
  title = {Antidepressant Use During Pregnancy and Birth Outcomes: Analysis From the UK , Norway, and Sweden},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2026},
  volume = {35},
  number = {9},
  doi = {10.1002/pds.70446}
}
Kostenlos starten →